Rare disease study seeks to understand family coping
NCT ID NCT07497581
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how children with rare diseases and their families adjust emotionally over time. Researchers will survey 240 families in German-speaking areas, asking about stress, coping, and communication. Some families will also report daily experiences via smartphone. The goal is to learn what helps families thrive, so better support can be designed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward better psychological support and targeted interventions for families coping with pediatric rare diseases.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly cure or treat any disease, and findings may not apply to all families or rare conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 240 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of families (children/adolescents and their caregivers) affected by a pediatric rare disease. Participants are recruited through two primary sources: * Clinical Source: Patients and their families are identified and recruited through supervising physicians at the University Children's Hospital Zurich, Switzerland. * Community Source: Families are also reached via patient organizations dedicated to rare diseases, using their mailing lists and communication channels. The population includes children and adolescents across various functional statuses (primarily somatic vs. primarily cognitive limitations) to capture a broad spectrum of family adaptation processes. Recruitment is focused on German-speaking families (with English as an additional option for caregivers) who reside at home, ensuring that the collected data reflects daily family life and relationship dynamics in a natural setting.
- Ages
-
1 year to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For children and adolescents: * Diagnosed with an RD listed in Table 2. * Age between 8 and 18 years. * Sufficient knowledge of the German language. * Declaration of informed consent must be signed by at least one legal guardian for all participants under 18; adolescents aged 14 - 17 additionally provide their own written consent. * Lives at home (defined as sleeping inside of the home for more than four days per week, including weekends). For parents: * The child is affected by an RD listed in Table 2. * The child's age is between 1 and 18 years. * Sufficient knowledge of the German or English language. * Availability of the signed declaration of informed consent. * Only one child with a diagnosed RD. * Up to two caregivers may participate per child. A stepparent may be included if they reside with the child, defined as spending at least three nights per week (including weekends) in the same household. * Requirement ESM: Child lives at home (defined as sleeping inside of the home for more than four days per week, including weekends). Exclusion Criteria: For children and adolescents: * The child is affected by an RD other than listed in Table 2. * Age under 8 or over 18 years. * Not sufficient knowledge of the German language. * Lack of informed consent from at least one legal guardian (required for all participants under 18); and, for adolescents aged 14 - 17, absence of adolescent's own written consent. * Lives outside of the home (defined as sleeping outside of the home for more than three days per week, including weekends). * Cognitive impairment. For parents: * The child is affected by an RD other than listed in Table 2. * The child's age is under 1 or over 18 years. * Not sufficient knowledge of the German nor English language. * Declaration of informed consent not signed. * More than one child with a diagnosed RD. * Requirement ESM: Child lives outside of the home (defined as sleeping outside of the home for more than three days per week, including weekends).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rare diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Children's Hospital Zurich
Zurich, 8008, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads faces to spot rare genetic diseases, but can it work across ethnicities?
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis
- New hope for kids with MVID: drug aims to cut diarrhea and IV needs